Cargando…

Successful treatment of rhinoorbital mucormycosis due to Rhizopus arrhizus with liposomal amphotericin B, posaconazole and surgical debridement in a child with neuroblastoma

Mucormycosis is a rare but potentially mortal opportunistic infection caused by Mucorales. We present a case of rhinoorbital mucormycosis in an 11-year old male with neuroblastoma successfully treated with aggressive surgical debridement and antifungal combination of liposomal amphotericin B and pos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Athanasiadou, Kleoniki I., Athanasiadis, Dimitrios I., Constantinidis, John, Anastasiou, Athanasia, Roilides, Emmanuel, Papakonstantinou, Evgenia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582074/ https://www.ncbi.nlm.nih.gov/pubmed/31245270 http://dx.doi.org/10.1016/j.mmcr.2019.06.003

Ejemplares similares

Successful Treatment of Mucormycosis Caused by Rhizopus arrhizus With Amphotericin B and Itraconazole
por: Cham, Chen Yi, et al.
Publicado: (2023)

Successful treatment of Rhizopus arrhizus rhino-orbital-cerebral mucormycosis with isavuconazole salvage therapy following extensive debridement
por: Miller, R.P., et al.
Publicado: (2021)

Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole
por: Ilharco, Marta, et al.
Publicado: (2019)

Ventriculitis due to infection with Rhizopus arrhizus
por: Hagel, Stefan, et al.
Publicado: (2015)

Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2020)

Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
por: Yuan, F., et al.
Publicado: (2021)

Cutaneous mucormycosis by Rhizopus arrhizus treated with isavuconazole as first line therapy: A case report
por: Zuglian, G., et al.
Publicado: (2019)

Pulmonary Infectious Complications in Children with Hematologic Malignancies and Chemotherapy-Induced Neutropenia
por: Voulgaridou, Aikaterini, et al.
Publicado: (2020)

An unusual cause of bowel obstruction: Rhizopus Arrhizus diverticulitis
por: Kou, Chungting, et al.
Publicado: (2019)

Necrotizing cellulitis due to Rhizopus arrhizus in an extremely premature infant
por: Hoyos, Álvaro, et al.
Publicado: (2020)

Case report of penile Rhizopus arrhizus infection in an unexpected patient
por: Bezzant, Matthew, et al.
Publicado: (2019)

Successful treatment of cutaneous mucormycosis disseminated from pulmonary mucormycosis with liposomal amphotericin B and posaconazole
por: Ding, Xiao-Lan, et al.
Publicado: (2020)

Successful therapy of progressive rhino-orbital mucormycosis caused by Rhizopus arrhizus with combined and sequential antifungal therapy, surgery and hyperbaric therapy
por: Imbernón, Adrián, et al.
Publicado: (2014)

Microbial Enhance of Chitosan Production by Rhizopus arrhizus Using Agroindustrial Substrates
por: Cardoso, Antonio, et al.
Publicado: (2012)

Dexamethasone: Rhizopus arrhizus infection and off label use: case report
Publicado: (2022)

Optimization of a Quantitative PCR Methodology for Detection of Aspergillus spp. and Rhizopus arrhizus
por: Mendonça, Alexandre, et al.
Publicado: (2022)

P217 Pelvic mycoses— an unusual presentation of Rhizopus arrhizus in an ommunocompetent patient
por: Khatod, Yash, et al.
Publicado: (2022)

Green Conversion of Agroindustrial Wastes into Chitin and Chitosan by Rhizopus arrhizus and Cunninghamella elegans Strains
por: Berger, Lúcia Raquel Ramos, et al.
Publicado: (2014)

Case Report: COVID-19-associated Rhinosinusitis Mucormycosis Caused by Rhizopus arrhizus: A Rare but Potentially Fatal Infection Occurring After Treatment with Corticosteroids
por: Tabarsi, Payam, et al.
Publicado: (2021)

P047 Comparative evaluation of disc diffusion and E-test with broth micro-dilution in susceptibility testing of amphotericin B, posaconazole, isuvuconazole, itraconazole against Rhizopus isolates of post COVID mucormycosis
por: Gupta, Prashant, et al.
Publicado: (2022)

Comparative immunopathogenesis in a murine model of inhalative infection with the mucormycetes Lichtheimia corymbifera and Rhizopus arrhizus
por: Rambach, Günter, et al.
Publicado: (2020)

Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to Rhizopus arrhizus (Syn. R. oryzae), the Principal Global Agent of Mucormycosis in Humans
por: Davies, Genna E., et al.
Publicado: (2022)

Amphotericin-b/dexamethasone/tocilizumab: Bronchopleural fistula, Rhizopus-associated mucormycosis and lack of efficacy: case report
Publicado: (2020)

Pulmonary Mucormycosis: An Interesting Case of Rhizopus Mucormycosis
por: Ukoha, Chijioke D, et al.
Publicado: (2021)

Novel Secreted Peptides From Rhizopus arrhizus var. delemar With Immunomodulatory Effects That Enhance Fungal Pathogenesis
por: Soliman, Sameh S. M., et al.
Publicado: (2022)

Fungal Invasive Co-Infection Due to Aspergillus fumigatus and Rhizopus arrhizus: A Rhino-Orbital Presentation
por: Ramírez-Hinojosa, Juan Pablo, et al.
Publicado: (2021)

Safety evaluation of the food enzyme triacylglycerol lipase from the non‐genetically modified Rhizopus arrhizus strain AE‐N
por: Lambré, Claude, et al.
Publicado: (2023)

Mucormycosis in a Severe Trauma Patient Treated with a Combination of Systemic Posaconazole and Topical Amphotericin B—Case Report
por: Keller, Filip, et al.
Publicado: (2023)

Safety evaluation of the food enzyme triacylglycerol lipase from the non‐genetically modified Rhizopus arrhizus strain AE‐TL(B)
por: Lambré, Claude, et al.
Publicado: (2023)

Purification and characterization of a cytochrome c with novel caspase-3 activation activity from the pathogenic fungus Rhizopus arrhizus
por: Saxena, Manoj, et al.
Publicado: (2015)

Case Report: Rhizopus arrhizus Rhino-Orbital-Cerebral Mycosis and Lethal Midline Granuloma: Another Fungal Etiological Agent
por: Li, Dong Ming, et al.
Publicado: (2021)

Hyphae of Rhizopus arrhizus and Lichtheimia corymbifera Are More Virulent and Resistant to Antifungal Agents Than Sporangiospores In Vitro and in Galleria mellonella
por: Samdavid Thanapaul, Rex Jeya Rajkumar, et al.
Publicado: (2023)

Safety evaluation of the food enzyme glucan 1,4‐α‐glucosidase from the non‐genetically modified Rhizopus arrhizus strain AE‐G
por: Lambré, Claude, et al.
Publicado: (2023)

Combination of Posaconazole and Amphotericin B in the Treatment of Candida glabrata Biofilms
por: Rodrigues, Célia F., et al.
Publicado: (2018)

Amphotericin-B-liposomal/posaconazole: Mixed transaminitis: case report
Publicado: (2021)

Amphotericin B liposomal/posaconazole: Lack of efficacy: case report
Publicado: (2022)

Erratum to: Purification and characterization of a cytochrome c with novel caspase-3 activation activity from the pathogenic fungus Rhizopus arrhizus
por: Saxena, Manoj, et al.
Publicado: (2016)

Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient
por: Anderson, Anthony, et al.
Publicado: (2017)

The successful use of amphotericin B followed by oral posaconazole in a rare case of invasive fungal sinusitis caused by co-infection with mucormycosis and aspergillus
por: Mahomed, Sharana, et al.
Publicado: (2015)

P173 PK PD rationale and efficacy of isavuconazole treatment after failure of amphotericin B and posaconazole for COVID-19 associated cranial Mucormycosis
por: Soman, Rajeev, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rm4no37ssab5v0fj7st6r6ojj3